BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rosa L, Tripepi G, Naldi E, Aimati M, Santangeli S, Venditto F, Caldarelli M, Valenti P. Ambulatory COVID-19 Patients Treated with Lactoferrin as a Supplementary Antiviral Agent: A Preliminary Study. J Clin Med 2021;10:4276. [PMID: 34575388 DOI: 10.3390/jcm10184276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Cutone A, Rosa L, Bonaccorsi di Patti MC, Iacovelli F, Conte MP, Ianiro G, Romeo A, Campione E, Bianchi L, Valenti P, Falconi M, Musci G. Lactoferrin Binding to SARS-CoV-2 Spike Glycoprotein Blocks Pseudoviral Entry and Relieves Iron Protein Dysregulation in Several In Vitro Models. Pharmaceutics 2022;14:2111. [PMID: 36297546 DOI: 10.3390/pharmaceutics14102111] [Reference Citation Analysis]
2 Morello R, De Rose C, Cardinali S, Valentini P, Buonsenso D. Lactoferrin as Possible Treatment for Chronic Gastrointestinal Symptoms in Children with Long COVID: Case Series and Literature Review. Children 2022;9:1446. [DOI: 10.3390/children9101446] [Reference Citation Analysis]
3 Darmawan KK, Karagiannis TC, Hughes JG, Small DM, Hung A. Molecular insights into the interaction of apo-lactoferrin with the receptor binding domain of the SARS-CoV-2 spike protein: a molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2121759] [Reference Citation Analysis]
4 Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J 2022;479:1653-708. [PMID: 36043493 DOI: 10.1042/BCJ20220154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ohradanova-repic A, Skrabana R, Gebetsberger L, Tajti G, Baráth P, Ondrovičová G, Praženicová R, Jantova N, Hrasnova P, Stockinger H, Leksa V. Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin. Front Immunol 2022;13:958581. [DOI: 10.3389/fimmu.2022.958581] [Reference Citation Analysis]
6 Rosa L, Cutone A, Conte MP, Campione E, Bianchi L, Valenti P. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection. Biometals 2022. [PMID: 35920949 DOI: 10.1007/s10534-022-00427-z] [Reference Citation Analysis]
7 Ward JL, Torres-gonzalez M, Ammons MCB. The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic. Nutrients 2022;14:3090. [DOI: 10.3390/nu14153090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Asmari M, Waqas M, Ibrahim AE, Halim SA, Khan A, Al-harrasi A, Wätzig H, El Deeb S. Microscale Thermophoresis and Molecular Modelling to Explore the Chelating Drug Transportation in the Milk to Infant. Molecules 2022;27:4604. [DOI: 10.3390/molecules27144604] [Reference Citation Analysis]
9 Bartolomé F, Rosa L, Valenti P, Lopera F, Hernández-Gallego J, Cantero JL, Orive G, Carro E. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients. Front Immunol 2022;13:878201. [PMID: 35547737 DOI: 10.3389/fimmu.2022.878201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Piacentini R, Centi L, Miotto M, Milanetti E, Di Rienzo L, Pitea M, Piazza P, Ruocco G, Boffi A, Parisi G. Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain. Int J Mol Sci 2022;23:5436. [PMID: 35628247 DOI: 10.3390/ijms23105436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gallo V, Giansanti F, Arienzo A, Antonini G. Antiviral properties of whey proteins and their activity against SARS-CoV-2 infection. J Funct Foods 2022;89:104932. [PMID: 35003332 DOI: 10.1016/j.jff.2022.104932] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
12 Ohradanova-repic A, Gebetsberger L, Tajti G, Ondrovičová G, Praženicová R, Skrabana R, Baráth P, Stockinger H, Leksa V. Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by the N-terminal peptide of lactoferrin.. [DOI: 10.1101/2021.12.20.473447] [Reference Citation Analysis]
13 Campione E, Lanna C, Cosio T, Rosa L, Conte MP, Iacovelli F, Romeo A, Falconi M, Del Vecchio C, Franchin E, Lia MS, Minieri M, Chiaramonte C, Ciotti M, Nuccetelli M, Terrinoni A, Iannuzzi I, Coppeta L, Magrini A, Bernardini S, Sabatini S, Rosapepe F, Bartoletti PL, Moricca N, Di Lorenzo A, Andreoni M, Sarmati L, Miani A, Piscitelli P, Squillaci E, Valenti P, Bianchi L. Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence. Int J Environ Res Public Health 2021;18:10985. [PMID: 34682731 DOI: 10.3390/ijerph182010985] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 17.0] [Reference Citation Analysis]